GPRC5D and Miyoshi myopathy: At relapse (15 months after the initiation of therapy), CD138+ MM cells demonstrated a large deletion (30.5 Mb) in the short arm of chromosome 12, encompassing the GPRC5D gene locus (Fig. 6g).